9 Rejected

Report annually on 'One Health' progress for phage technologies and therapies

Recommendation
The Government, the World Health Organisation and a number of the witnesses we heard from have highlighted the importance of a “One Health” approach to tackling AMR across sectors including human and animal health, the food supply chain, and the environment. The Department of Health and Social Care (DHSC) and others told us that phages could play an important role in delivering this approach. However, the DHSC acknowledged that they were at an early stage of tracking progress on phages. We believe it is important that—if phages are to play a meaningful part in a ‘One Health’ approach to tackling AMR—progress is reported in a timely and comprehensive manner. We recommend that the DHSC, as the lead department on AMR, reports annually on the progress made on evaluating and developing all phage- related technologies and therapies that affect human, animal or environmental health (referred to as the ‘One Health’ approach). This should be a joined-up assessment bringing together analyses and data from all relevant departments, regulators, public bodies and funders who are in receipt of public funding for work on phages.
Government Response Summary
The government rejects the recommendation to produce annual reports exclusively focused on phages, stating it is reluctant to prioritize any one technology, but will regularly review progress on its 5-year AMR National Action Plan, which will include phages.
Paragraph Reference
63
Government Response
Rejected
HM Government Rejected
The government recognises the importance of exploring a range of different approaches to develop a comprehensive response to AMR domestically, internationally and across sectors. The government recognises the importance of research into non-traditional therapies, such as phages, as a potential part of the toolkit for tackling AMR. The government will continue to work with partner organisations to monitor the AMR clinical and research pipeline, including the growing evidence base for phage therapy, in line with the 'One Health' approach to tackling AMR. The government is committed to taking a holistic approach to tackling AMR and is reluctant to prioritise any one technology in terms of funding or reporting. For this reason, the government will not produce annual reports that focus exclusively on phages. The government will, however, regularly review progress in delivering its 5-year AMR NAP 2024 to 2029, which will include, but will not be limited to, phages.
Addressee Bodies
Department for Science, Innovation and Technology
Timeline
Recommendation age 2.4 yrs
Report published 03 Jan 2024